Container
Latest Bristol-Myers Squibb Company Patents:
- Therapeutic immunoglobulin G4 for improved bioanalytical and bioprocessing properties
- Hepatitis C virus inhibitors
- UREA ANTAGONISTS OF P2Y1 RECEPTOR USEFUL IN THE TREATMENT OF THROMBOTIC CONDITIONS
- Six-membered heterocycles useful as serine protease inhibitors
- COMBINATION OF SRC KINASE INHIBITORS AND CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF PROLIFERATIVE DISEASES
Description
FIG. 1 is a perspective view of a container embodying our new design;
FIG. 2 is a front elevational view thereof, the rear elevational view being identical;
FIG. 3 is a right side elevational view thereof, the left side elevational view being identical; and,
FIG. 4 is a top plan view thereof.
Claims
The ornamental design for a container, substantially as shown and described.
Referenced Cited
U.S. Patent Documents
Other references
| D221169 | July 1971 | Benes |
| D225730 | January 1973 | Peterson |
| D241917 | October 1976 | Borum |
| D259625 | June 23, 1981 | Hamilton et al. |
| D339958 | October 5, 1993 | Olsen et al. |
| D370300 | May 28, 1996 | Gottvald et al. |
| D405609 | February 16, 1999 | Fu et al. |
| D453892 | February 26, 2002 | Lindsay et al. |
| D456265 | April 30, 2002 | Spear |
| D474377 | May 13, 2003 | Holsinger |
| D474651 | May 20, 2003 | Ward |
| D502396 | March 1, 2005 | Frisch et al. |
- (Pending) U.S. Appl. No. 29/206,122, filed May 26, 2004.
- (Pending) U.S. Appl. No. 60/574,411, filed May 26, 2004.
- (Pending) U.S. Appl. No. 29/206,084, filed May 26, 2004.
- (Pending) U.S. Appl. No. 29/206,083, filed May 26, 2004.
- (Pending) U.S. Appl. No. 29/206,079, filed May 26, 2004.
Patent History
Patent number: D539655
Type: Grant
Filed: Feb 2, 2005
Date of Patent: Apr 3, 2007
Assignee: Bristol-Myers Squibb Company (Princeton, NJ)
Inventors: Stuart R. Kipperman (Evansville, IN), Cathy O. Smay (Newburgh, IN)
Primary Examiner: Ian Simmons
Assistant Examiner: Dana Sipos
Attorney: Nelson Mullins Riley & Scarborough, LLP
Application Number: 29/222,722
Type: Grant
Filed: Feb 2, 2005
Date of Patent: Apr 3, 2007
Assignee: Bristol-Myers Squibb Company (Princeton, NJ)
Inventors: Stuart R. Kipperman (Evansville, IN), Cathy O. Smay (Newburgh, IN)
Primary Examiner: Ian Simmons
Assistant Examiner: Dana Sipos
Attorney: Nelson Mullins Riley & Scarborough, LLP
Application Number: 29/222,722
Classifications
Current U.S. Class:
D9/529;
D9/558